BEAM
Price
$19.53
Change
-$0.64 (-3.17%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
2.03B
17 days until earnings call
HALO
Price
$60.53
Change
+$1.28 (+2.16%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
7.47B
17 days until earnings call
Ad is loading...

BEAM vs HALO

Header iconBEAM vs HALO Comparison
Open Charts BEAM vs HALOBanner chart's image
Beam Therapeutics
Price$19.53
Change-$0.64 (-3.17%)
Volume$18.23K
Capitalization2.03B
Halozyme Therapeutics
Price$60.53
Change+$1.28 (+2.16%)
Volume$13.86K
Capitalization7.47B
BEAM vs HALO Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. HALO commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and HALO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (BEAM: $19.52 vs. HALO: $60.49)
Brand notoriety: BEAM and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 49% vs. HALO: 65%
Market capitalization -- BEAM: $2.03B vs. HALO: $7.47B
BEAM [@Biotechnology] is valued at $2.03B. HALO’s [@Biotechnology] market capitalization is $7.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $276.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while HALO’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • HALO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HALO is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +14.82% price change this week, while HALO (@Biotechnology) price change was +2.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.17%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was -10.42%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

HALO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.47B) has a higher market cap than BEAM($2.03B). HALO YTD gains are higher at: 26.522 vs. BEAM (-21.290). HALO has higher annual earnings (EBITDA): 657M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. HALO (596M). BEAM has less debt than HALO: BEAM (161M) vs HALO (1.51B). HALO has higher revenues than BEAM: HALO (1.02B) vs BEAM (63.5M).
BEAMHALOBEAM / HALO
Capitalization2.03B7.47B27%
EBITDA-383.98M657M-58%
Gain YTD-21.29026.522-80%
P/E RatioN/A17.27-
Revenue63.5M1.02B6%
Total Cash851M596M143%
Total Debt161M1.51B11%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
11
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMHALO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 22 days ago
85%
Bearish Trend 5 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCCNX68.49N/A
N/A
Fidelity Advisor Canada C
EICIX17.46N/A
N/A
EIC Value Institutional
NSMAX29.02N/A
N/A
Nuveen Small/Mid-Cap Value A
OIEPX22.89N/A
N/A
JPMorgan Equity Income R3
BGESX12.77N/A
N/A
Baillie Gifford International Growth I